1. A multi‐centre phase I trial of the PARP inhibitor olaparib in patients with relapsed chronic lymphocytic leukaemia, T‐prolymphocytic leukaemia or mantle cell lymphoma. (23rd June 2017) Authors: Pratt, Guy; Yap, Christina; Oldreive, Ceri; Slade, Daniel; Bishop, Rebecca; Griffiths, Mike; Dyer, Martin J. S.; Fegan, Chris; Oscier, David; Pettitt, Andrew; Matutes, Estella; Devereux, Stephen; Allsup, David; Bloor, Adrian; Hillmen, Peter; Follows, George; Rule, Simon; Moss, Paul; Stankovic, Ta... Journal: British journal of haematology Issue: Volume 182:Number 3(2018) Page Start: 429 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗